0.189
Finanzdaten der Silexion Therapeutics Corp-Aktie (SLXN)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
33.87%
3.68
|
2.749 | 4.406 | 3.292 | 2.284 |
| Operating Income/Loss |
33.87%
-3.68
|
-2.749 | -4.406 | -3.292 | -2.284 |
| Nonoperating Income/Loss |
706.25%
-0.129
|
-0.016 | 0.006 | -0.03 | 0.216 |
| Income/Loss From Continuing Operations Before Tax |
29.93%
-3.551
|
-2.733 | -4.412 | -3.262 | -2.50 |
| Net Income/Loss |
29.93%
-3.551
|
-2.733 | -4.412 | -3.262 | -2.503 |
| Basic Average Shares |
78.72%
0.6874
|
3.2304 | - | 1.1327 | 0.5795 |
| Diluted Average Shares |
78.72%
0.6874
|
3.2304 | - | 1.1327 | 0.5795 |
| Basic Earnings Per Share |
508.24%
5.17
|
0.85 | - | 2.88 | 4.32 |
| Diluted Earnings Per Share |
508.24%
5.17
|
0.85 | - | 2.88 | 4.32 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):